Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nutritional Therapy vs Lactulose for Secondary Prophylaxis of Hepatic Encephalopathy
NCT03161106Withdrawn
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- May 2017
- Primary completion
- Oct 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in hepatic encephalopathy (HE), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Number of patients develop hepatic encephalopathy at 6 months. Planned start May 2017; status: withdrawn.
02
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03161106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03161106.